A perception-based nanosensor platform to detect cancer biomarkers

Zvi Yaari1, Yoona Yang2, Elana Apfelbaum1

  • 1Memorial Sloan Kettering Cancer Center, NY, New York 10065, USA.

Science Advances
|November 19, 2021
PubMed
Summary

This study introduces a novel perception-based platform using optical nanosensors and machine learning for detecting multiple cancer biomarkers in biofluids. This approach offers a faster, cost-effective alternative to traditional antibody-based methods for disease diagnostics.

Related Concept Videos